Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nina Kim, Joaquin Estrada, Isabella Chow, Aleksandrina Ruseva, Abhilasha Ramasamy, Chakkarin Burudpakdee & Christopher M Blanchette. (2023) The Relative Value of Anti-Obesity Medications Compared to Similar Therapies. ClinicoEconomics and Outcomes Research 15, pages 51-62.
Read now
Read now
João Mauricio Castaldelli-Maia, Victoria Camargos de Oliveira, Flávia Mariana Irber, Israel K. Blaas, Bernard Angerville, Anderson Sousa Martins-da-Silva, Gislaine Koch Gimenes, Marcela Waisman Campos, Julio Torales, Antonio Ventriglio, Carine Guillois, Houria El Ouazzani, Léna Gazaix, Pascal Favré, Alain Dervaux & Gisèle Apter. (2023) Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders. International Review of Psychiatry 35:5-6, pages 397-417.
Read now
Read now
Siddharth Bhargava, Ranjani Panda, Asma M Azam & John D Sheppard. (2023) A review of dry eye disease therapies: exploring the qualities of varenicline solution nasal spray. Expert Review of Ophthalmology 18:1, pages 1-10.
Read now
Read now
Jeremy Mills. (2022) Varenicline (Chantix): The Smoking Cessation Medication Prescribers May Be Avoiding. Issues in Mental Health Nursing 43:5, pages 489-494.
Read now
Read now
Articles from other publishers (25)
Layne E. Robinson, Nathan Didier, Riya Thomas, Ashley VenaAndrea King. (2024) Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Outcomes in Heavy Drinkers at 26-Week Follow-up. Journal of Clinical Psychopharmacology.
Crossref
Crossref
Robert Schnoll, E Paul Wileyto, Anna-Marika Bauer, Erica N Fox, Daniel Blumenthal, Mackenzie Hosie Quinn, Frank Leone, Mark D Huffman, Sadiya S Khan, Jacqueline K Gollan, George D Papandonatos & Brian Hitsman. (2024) Seeing Through the Blind: Belief About Treatment Randomization and Smoking Cessation Outcome Among People With Current or Past Major Depressive Disorder Who Smoke in a Placebo-Controlled Trial of Varenicline. Nicotine and Tobacco Research 26:5, pages 597-603.
Crossref
Crossref
Nadia Minian, Melissa Wong, Sowsan Hafuth, Terri Rodak, Alma Rahimi, Dea Gjomema, Jonathan Rose, Laurie Zawertailo, Matt Ratto & Peter Selby. (2024) Identifying determinants of varenicline adherence using the Theoretical Domains framework: a rapid review. BMC Public Health 24:1.
Crossref
Crossref
Kyle Arsenault‐Mehta, Mario Hochman‐Bérard, Alexander Johnson, Dar'ya Semenova, Bea Nguyen, Jessie Willis, Natalia Mouravska, Ridha Joober & Naista Zhand. (2023) Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review. Neuropsychopharmacology Reports 44:1, pages 2-16.
Crossref
Crossref
Alessio Crestini, Elena Carbone, Roberto Rivabene, Antonio Ancidoni, Paolo Rosa, Ada Maria Tata, Elisa Fabrizi, Nicoletta Locuratolo, Nicola Vanacore, Eleonora Lacorte & Paola Piscopo. (2024) A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia. Cells 13:3, pages 237.
Crossref
Crossref
Hermann A.M. Mucke. (2023) Drug Repurposing Patent Applications July–September 2023. ASSAY and Drug Development Technologies.
Crossref
Crossref
Rohan Gupta, Dia Advani, Divya Yadav, Rashmi K Ambasta & Pravir Kumar. (2023) Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders. Molecular Neurobiology 60:11, pages 6476-6529.
Crossref
Crossref
Edouard Montigné & David Balayssac. (2023) Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies. Pharmaceuticals 16:10, pages 1363.
Crossref
Crossref
Louisa A. Christie, Nicola L. Brice, Anna Rowland, Louise Dickson, Rishi Anand, Martin Teall, Kevin J. Doyle, Lakshminarayana Narayana, Christine Mitchell, Jenna R. M. Harvey, Victoria Mulligan, Lee A. Dawson, Stephanie J. Cragg, Mark Carlton & Roland W. Bürli. (2023)
Discovery of
CVN417
, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
. Journal of Medicinal Chemistry 66:17, pages 11718-11731.
Crossref
Crossref
Mariaelvina SALA & Cecilia GOTTI. (2023) Electronic nicotine delivery systems (ENDS): A convenient means of smoking?. Pharmacological Research 195, pages 106885.
Crossref
Crossref
Katherine Huerne & Mark J. Eisenberg. (2023) Vaping-Cessation Interventions in Former Smokers. Canadian Journal of Cardiology 39:9, pages 1263-1267.
Crossref
Crossref
Kinsey Pebley, Zoran Bursac, Robert C. Klesges, Jon O. Ebbert, Catherine R. Womack, Julia Graber, Melissa A. Little, Karen J. Derefinko & Rebecca A. Krukowski. (2023) A randomized controlled trial to reduce post-cessation weight gain. International Journal of Obesity 47:6, pages 471-478.
Crossref
Crossref
Ashish R. Patel, Jigar R. Panchal & Chetna K. Desai. (2023) Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials. Indian Journal of Psychiatry 65:5, pages 526-533.
Crossref
Crossref
Catarina Rodrigues Cordeiro, Beatriz Romão Côrte-Real, Rodrigo Saraiva, Benicio N. Frey, Flavio Kapczinski & Taiane de Azevedo Cardoso. (2023) Triggers for acute mood episodes in bipolar disorder: A systematic review. Journal of Psychiatric Research 161, pages 237-260.
Crossref
Crossref
Choon-Young Kim. (2022) Recent Trends of Research and Guidelines on Pharmacotherapy for Smoking Cessation. Journal of the Korean Society for Research on Nicotine and Tobacco 13:4, pages 107-115.
Crossref
Crossref
Kangle Guo, Liying Zhou, Xue Shang, Chaoqun Yang, Fenfen E, Yan Wang, Meng Xu, Yanan Wu, Yanfei Li, Meixuan Li, Kehu Yang & Xiuxia Li. (2022) Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis. Drug and Alcohol Dependence 241, pages 109672.
Crossref
Crossref
Alejandra Ellison-Barnes & Panagis Galiatsatos. (2022) Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. Medical Clinics of North America 106:6, pages 1067-1080.
Crossref
Crossref
Oruç YUNUSOĞLU, Çagla KÖSE, Sibel ÖZYAZGAN, Andleeb SHAHZADİ, Bülent DEMİR, Burak ÖNAL & Ahmet Gökhan AKKAN. (2022) Sıçanlarda Bupropion ve Vareniklinin Morfin Yoksunluğu Sendromu Üzerine Etkileri. Bolu Abant Izzet Baysal Universitesi Tip Fakultesi Abant Tip Dergisi.
Crossref
Crossref
Yu-Han Zhang, Ning Wang, Xiao-Xiao Lin, Jin-Yan Wang & Fei Luo. (2022) Application of Cognitive Bias Testing in Neuropsychiatric Disorders: A Mini-Review Based on Animal Studies. Frontiers in Behavioral Neuroscience 16.
Crossref
Crossref
Min-Gyo Jang, Hyun-Jin Gu, Junwoo Kim & Kwang-Hee Shin. (2022) Signal detection for adverse event of varenicline in Korea Adverse Event Reporting System. Korean Journal of Clinical Pharmacy 32:1, pages 1-7.
Crossref
Crossref
Ju Sam Hwang & Cheol Min Lee. (2021) Recent Updates of Pharmacotherapy for Smoking Cessation. Korean Journal of Family Practice 11:6, pages 403-414.
Crossref
Crossref
Divya Jain, Priya Chaudhary, Nidhi Varshney, Khandaker Sabit Bin Razzak, Devret Verma, Tasnim Reza Khan Zahra, Pracheta Janmeda, Javad Sharifi-Rad, Sevgi Durna Daştan, Shafi Mahmud, Anca Oana Docea & Daniela Calina. (2021) Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis. Journal of Oncology 2021, pages 1-11.
Crossref
Crossref
Jeffrey Nau, David J. Wyatt, Hans Rollema & Christopher S. Crean. (2021) A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline. Clinical Therapeutics 43:9, pages 1595-1607.
Crossref
Crossref
Ebenezer O Oloyede, Olatunde Ola, Victor O Kolade & Justin Tevie. (2021) Looking Back and Going Forward: Roles of Varenicline and Electronic Cigarettes in Smoking Cessation. Cureus.
Crossref
Crossref
Louise Carton, Mikaïl Nourredine & Benjamin Rolland. (2021) Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN). Therapies 76:2, pages 127-136.
Crossref
Crossref